FDC India

FDC India

FDC.NS
Mumbai, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

FDC.NS · Stock Price

INR 375.55-54.00 (-12.57%)
Market Cap: $655.2M

Historical price data

Market Cap: $655.2MFounded: 1936Employees: 8000-10000HQ: Mumbai, India

Overview

FDC Limited's mission is to provide high-quality, affordable branded generic medicines and healthcare products. Its key achievements include establishing dominant market positions with flagship brands like Electral ORS, building a vertically integrated manufacturing model with international certifications, and maintaining a consistent financial performance as a publicly listed entity. The company's strategy centers on deepening its penetration in core therapeutic segments, expanding its portfolio of complex generics and novel drug delivery systems, and selectively growing its international footprint in regulated and emerging markets.

GastroenterologyVitamins & MineralsAnti-infectivesDermatology

Technology Platform

Advanced formulation development and Novel Drug Delivery Systems (NDDS) for complex generics, supported by vertically integrated API manufacturing and regulatory expertise.

Funding History

1
IPOUndisclosed

Opportunities

Significant growth driven by the expanding Indian pharmaceutical market, increasing global demand for affordable generics, and the rising health consciousness fueling the nutraceuticals segment.
The company's focus on complex generics and novel drug delivery systems opens higher-margin niches.

Risk Factors

Faces intense regulatory scrutiny and compliance risks across manufacturing sites.
Significant pricing pressure from competition and government controls in key markets, alongside concentration risk from reliance on flagship brands like Electral.

Competitive Landscape

Competes with large Indian pharma peers (Sun Pharma, Cipla) and global generic manufacturers. Differentiates through strong domestic brand equity, vertical integration for cost/quality control, and a focus on complex formulations within its core therapeutic areas.